MXPA02012100A - Sal de tiazodilindiona para el tratamiento de la diabetes mellitus. - Google Patents

Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.

Info

Publication number
MXPA02012100A
MXPA02012100A MXPA02012100A MXPA02012100A MXPA02012100A MX PA02012100 A MXPA02012100 A MX PA02012100A MX PA02012100 A MXPA02012100 A MX PA02012100A MX PA02012100 A MXPA02012100 A MX PA02012100A MX PA02012100 A MXPA02012100 A MX PA02012100A
Authority
MX
Mexico
Prior art keywords
treatment
diabetes mellitus
compound
thiazolidinedione
salt
Prior art date
Application number
MXPA02012100A
Other languages
English (en)
Inventor
Andrew Simon Craig
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MXPA02012100A publication Critical patent/MXPA02012100A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Se describe un compuesto farmaceutico novedoso, el bromohidrato de 5-[4-[2-(N-metiI-N-(2-piridil)amino)etoxi]bencil] tiazolidin-2,4-diona o un solvato del mismo, un procedimiento para la preparacion de tal compuesto, una composicion farmaceutica que comprende tal compuesto y el uso de tal compuesto en medicina.
MXPA02012100A 2000-06-08 2001-06-08 Sal de tiazodilindiona para el tratamiento de la diabetes mellitus. MXPA02012100A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
MXPA02012100A true MXPA02012100A (es) 2003-04-25

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012100A MXPA02012100A (es) 2000-06-08 2001-06-08 Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.

Country Status (23)

Country Link
EP (1) EP1296980A1 (es)
JP (1) JP2003535862A (es)
KR (1) KR20030007918A (es)
CN (1) CN1443186A (es)
AP (1) AP2002002673A0 (es)
AU (1) AU2001264078A1 (es)
BG (1) BG107357A (es)
BR (1) BR0111536A (es)
CA (1) CA2411065A1 (es)
CZ (1) CZ20023966A3 (es)
DZ (1) DZ3382A1 (es)
EA (1) EA200300005A1 (es)
GB (1) GB0014006D0 (es)
HU (1) HUP0301137A3 (es)
IL (1) IL153279A0 (es)
MA (1) MA25753A1 (es)
MX (1) MXPA02012100A (es)
NO (1) NO20025883L (es)
OA (1) OA12284A (es)
PL (1) PL360592A1 (es)
SK (1) SK17142002A3 (es)
WO (1) WO2001094344A1 (es)
ZA (1) ZA200209954B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
WO2008091624A2 (en) * 2007-01-22 2008-07-31 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
HUP0301137A2 (hu) 2003-08-28
EA200300005A1 (ru) 2003-04-24
CN1443186A (zh) 2003-09-17
KR20030007918A (ko) 2003-01-23
AP2002002673A0 (en) 2002-12-31
WO2001094344A1 (en) 2001-12-13
NO20025883D0 (no) 2002-12-06
JP2003535862A (ja) 2003-12-02
SK17142002A3 (sk) 2003-10-07
ZA200209954B (en) 2003-10-10
AU2001264078A1 (en) 2001-12-17
PL360592A1 (en) 2004-09-20
EP1296980A1 (en) 2003-04-02
CZ20023966A3 (cs) 2003-04-16
GB0014006D0 (en) 2000-08-02
BR0111536A (pt) 2003-07-01
DZ3382A1 (fr) 2001-12-13
HUP0301137A3 (en) 2005-04-28
OA12284A (en) 2003-11-10
BG107357A (bg) 2003-08-29
IL153279A0 (en) 2003-07-06
MA25753A1 (fr) 2003-04-01
NO20025883L (no) 2003-02-03
CA2411065A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP1562A (en) Thiazolidinedione derivatives and its use as antidiabetic.
PT1349855E (pt) Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
NZ524933A (en) Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof